Mingxin Xuteng announced that the daily closing price increase deviation value of the company's stock exceeded 20% for two consecutive trading days on July 29 and 30, 2026, which was an abnormal fluctuation. The company expects a net loss of 35 million to 52 million yuan for the semi-annual period of 2026, and the expected loss will increase compared with the same period in 2025; the holding subsidiary, Liaoning Fuxin, has stopped production and is expected to be prepared for impairment of about 10 million yuan. Furthermore, although some media have included the company in the “humanoid robot concept” section, the company's business is not involved in this field, and related technology exploration is still in its early stages, and no orders or industrialization capabilities have been formed.

Mingxin Xuteng announced that the daily closing price increase deviation value of the company's stock exceeded 20% for two consecutive trading days on July 29 and 30, 2026, which was an abnormal fluctuation. The company expects a net loss of 35 million to 52 million yuan for the semi-annual period of 2026, and the expected loss will increase compared with the same period in 2025; the holding subsidiary, Liaoning Fuxin, has stopped production and is expected to be prepared for impairment of about 10 million yuan. Furthermore, although some media have included the company in the “humanoid robot concept” section, the company's business is not involved in this field, and related technology exploration is still in its early stages, and no orders or industrialization capabilities have been formed.